BearingPoint Welcomes 11 New Partners
1.7.2020 10:00:00 EEST | Business Wire | Press release
Management and technology consultancy BearingPoint announced today that it has promoted 11 new Partners across Europe. The promotions underline the firm's ongoing success and growth and the ambitions defined in its Strategy 2025: put people in the center, outperform the market every year, and be in the top three in chosen areas of expertise.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200701005095/en/
Kiumars Hamidian, Managing Partner at BearingPoint (Photo: Business Wire)
Kiumars Hamidian, Managing Partner at BearingPoint, said, "It is a real pleasure welcoming 11 new Partners to our Partner-led firm. These promotions move us forward along our Strategy 2025. We help our people develop professionally and are building a firm that will stand strong for future generations. Even in these difficult times, we strongly believe in taking a long-term view. All of our new Partners worked hard to achieve this milestone in their career, and all of them will contribute shaping our future and creating value for our clients."
The new Partners at a glance:
Vebjørn Axelsen
Office: Oslo/Norway
With BearingPoint since: 2007
Education: Master's in Computer Science with specialization in artificial intelligence and algorithms
Areas of responsibility: Advanced Analytics and AI in Norway
"My objective is to deliver on the promise of data-driven analytics as an essential component of business improvement across industries."
Jean-Charles Chevalier
Office: Paris/France
With BearingPoint since: 2008
Education: Master's in International Finance
Areas of responsibility: co-lead of the Business Strategy offerings with a focus on M&A in France
"My objective is to strengthen and accelerate the development of our Business Strategy and Transformation activities and promote our offerings related to M&A. I will also have the responsibility for the account management of Accor."
Tomas Chroust
Office: Zurich/Switzerland
With BearingPoint since: 2008
Education: Master's in international economic and business studies
Areas of responsibility: cross-industry Technology Partner, Head for Data & Analytics / Artificial Intelligence in the region Germany/Switzerland/Austria.
"My focus is on the conception, design and implementation of technology-driven digital transformation. My view is: If you really want to do something, you will find a way."
Chrystel Dierking
Office: Paris/France
With BearingPoint since: 2014
Education: Master's in International Finance
Areas of responsibility: Finance & Regulations
"I'm aiming to transform the Financial function for our clients towards CFO 4.0 and develop assets and IP for their performance management area. We have a strong focus on accelerating new ways of working, putting people transformation at the heart of each project."
Moritz Kauder
Office: Frankfurt/Germany
With BearingPoint since: 2005
Education: Master's in Business Informatics
Areas of responsibility: Technology with a focus on process automation & digitalization, robotization and operational excellence.
“With our Operations 4.0 approach we help our clients to make their operating models more efficient and agile, less expensive and fit for future by seizing technology.”
Patrick Kirchhof
Office: Dusseldorf/Germany
With BearingPoint since: 2010
Education: Doctoral degree in Economics, Master's in Business and Information Technology
Areas of responsibility: Operations in the Automotive segment
"As a Partner in our Automotive Industry segment, I will continue to advise and support our clients on their digital transformation journey with a focus on operations. I am passionate about both innovation itself and the process of bringing it to life. Beyond that, I drive the creation and project delivery of our in-house IP-asset' Factory Navigator' designed to accelerate our clients' digitalization initiatives and optimize their production and logistics performance."
Anna Kremer
Office: Zurich/Switzerland
With BearingPoint since: 2019
Education: Master's in Business Administration
Areas of responsibility: Finance & Regulations
"I am looking forward to this great opportunity to deepen our footprint for CFO services in Switzerland. We will focus, on the one hand, on extending our SAP backbone for Accounting, Controlling, Reporting, Planning and Consolidation. On the other hand, we will be highly engaged to extend our CFO 4.0 approach, which will enable our clients to transform their Finance departments into an innovative and digitalized business partner role."
Andreas Mitter
Office: Vienna/Austria
With BearingPoint since: 2006
Education: Master's in Internet Technology & Management
Areas of responsibility: Agile Advisory and Agile Software Engineering
"As a Partner, I will do everything I can to continue to make BearingPoint the top address for management consulting and the best consultancy for Agile Transformation and Coaching."
Thomas Pinel
Office: Paris/France
With BearingPoint since: 2000
Education: Master's in engineering, and Master's in Business Administration
Areas of responsibility: development of our Salesforce activities
"I am looking forward to accelerating the digital transformation of our clients in a challenging business context."
Janice Spindler
Office: Paris/France
With BearingPoint since: 2005
Education: Master's in Technology and Management (Hons.)
Areas of responsibility: consumer goods and retail with focus on fashion-luxury accounts
"As a Partner, I am committed to supporting our retail industry clients in their fast and efficient move towards unified commerce. I am dedicated to advancing our retail ecosystem, leveraging our technology partners and best-in-class consultants."
Reto Tomasini
Office: Zurich/Switzerland
With BearingPoint since: 2010
Education: Master's in Developmental Biology
Areas of responsibility: IEM (Industrial Equipment and Manufacturing) in Switzerland
"I aim for excellence in execution and client satisfaction, leading to long-term, mutually successful business relationships. Our manufacturing advisory in Switzerland focuses on business and IT transformations, areas of innovation within Industry 4.0, IoT and Digital Twins, as well as the promotion of our own smart software solutions and business services."
About BearingPoint
BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: The first unit covers the advisory business with a clear focus on five key areas to drive growth across all regions. The second unit provides IP-driven managed services beyond SaaS and offers business critical services to its clients supporting their business success. The third unit provides the software for successful digital transformation and regulatory requirements. It is also designed to explore innovative business models with clients and partners by driving the financing and development of start-ups and leveraging ecosystems.
BearingPoint's clients include many of the world's leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.
For more information, please visit:
Homepage: www.bearingpoint.com
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200701005095/en/
Contact information
Alexander Bock
Global Manager Communications
Telephone: +49 89 540338029
E-Mail: alexander.bock@bearingpoint.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 13:38:00 EEST | Press release
For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will
Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 12:48:00 EEST | Press release
Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom